Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jul 15, 2019
Company News
Management tracks: GSK, Orphazyme, Kymera and more
...The protein degradation company also hired Bruce Jacobs as CFO. Jacobs was managing partner at
Westfield Capital
...
Read More
BioCentury
|
Sep 15, 2008
Finance
Ebb & Flow
...hematologic malignancies and solid tumors. New investor Nomura Phase4 led the round. Another new investor,
Westfield Capital
...
Read More
BioCentury
|
Sep 9, 2008
Financial News
Proteolix raises $79 million
...$79 million in a series C round led by new investor Nomura Phase4. New investor
Westfield Capital
...
Read More
BioCentury
|
Jul 16, 2008
Financial News
Collegium raises $20 million
...a series D round led by Frazier Healthcare Ventures. Existing investors Boston Millennia Partners and
Westfield Capital
...
Read More
BioCentury
|
May 26, 2008
Finance
Ebb & Flow
...with the neurology diagnostics products business of Medtronic (NYSE:MDT). Private equity tracks Lawrence Fritz joined
Westfield Capital
...
Read More
BioCentury
|
May 1, 2008
Financial News
Concert raises $37 million
...investor. Other participants were new investors Adage Capital Management; SR One; Mediphase Venture Partners; and
Westfield Capital
...
Read More
BioCentury
|
Mar 24, 1997
Emerging Company Profile
Ontogeny Inc.
...Liberty; Charles River; Medical Science Partners; Mehta & Isaly; New York Life; Invesco; Vulcan Ventures;
Westfield Capital
...
Read More
Items per page:
10
1 - 7 of 7
BioCentury
|
Jul 15, 2019
Company News
Management tracks: GSK, Orphazyme, Kymera and more
...The protein degradation company also hired Bruce Jacobs as CFO. Jacobs was managing partner at
Westfield Capital
...
Read More
BioCentury
|
Sep 15, 2008
Finance
Ebb & Flow
...hematologic malignancies and solid tumors. New investor Nomura Phase4 led the round. Another new investor,
Westfield Capital
...
Read More
BioCentury
|
Sep 9, 2008
Financial News
Proteolix raises $79 million
...$79 million in a series C round led by new investor Nomura Phase4. New investor
Westfield Capital
...
Read More
BioCentury
|
Jul 16, 2008
Financial News
Collegium raises $20 million
...a series D round led by Frazier Healthcare Ventures. Existing investors Boston Millennia Partners and
Westfield Capital
...
Read More
BioCentury
|
May 26, 2008
Finance
Ebb & Flow
...with the neurology diagnostics products business of Medtronic (NYSE:MDT). Private equity tracks Lawrence Fritz joined
Westfield Capital
...
Read More
BioCentury
|
May 1, 2008
Financial News
Concert raises $37 million
...investor. Other participants were new investors Adage Capital Management; SR One; Mediphase Venture Partners; and
Westfield Capital
...
Read More
BioCentury
|
Mar 24, 1997
Emerging Company Profile
Ontogeny Inc.
...Liberty; Charles River; Medical Science Partners; Mehta & Isaly; New York Life; Invesco; Vulcan Ventures;
Westfield Capital
...
Read More
Items per page:
10
1 - 7 of 7
Previous page
Next page